Last reviewed · How we verify

NCT06271694: APV

Activity and Participation in Vestibular Disorders

Completed NA Last updated 30 March 2026
What this trial tests

NA trial testing Vestibular Rehabilitation in Vestibular Disorder in 52 participants. Completed in 6 February 2026.

Timeline
12 January 2024
Primary endpoint
6 February 2026
6 February 2026

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment52
Start date12 January 2024
Primary completion6 February 2026
Estimated completion6 February 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Adults 18 to 100, any sex, with Vestibular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine whether impairments and personal factors are associated with activity and participation in people with vestibulopathy. Data collection will occur prior to starting vestibular rehabilitation and after completing vestibular rehabilitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vestibular Rehabilitation

Trials testing the same drug.

Other recruiting trials for Vestibular Disorder

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06271694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing